HSPA2 and breast carcinoma: Interestingly, high expression of HSPA2 and DNAJC20 was significantly associated with better prognosis for breast cancer patients from TCGA cohort (p = 6,4e-03 and p = 4,3e-02, respectively), longer overall survival in KM plotter cohort (p = 4,5e-04 and p = 5,3e-03, respectively) and longer relapse-free survival in KM plotter cohort (p = 1,5e-07 and p = 5,3e-12, respectively) (Figs 1A, S3).